Down -88.84% in 4 Weeks, Here's Why HilleVax (HLVX) Looks Ripe for a Turnaround

Group 1 - HilleVax, Inc. (HLVX) has experienced significant selling pressure, resulting in an 88.8% loss over the past four weeks, but analysts expect better earnings than previously predicted [1] - The stock is currently in oversold territory, indicated by a Relative Strength Index (RSI) reading of 15.88, suggesting a potential reversal in trend [5] - There has been a 19.2% increase in the consensus EPS estimate for HLVX over the last 30 days, driven by a strong agreement among sell-side analysts to raise earnings estimates [6] Group 2 - HLVX holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, indicating a potential turnaround [7]